Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Liao, Wen Ting ^a,b,c   Yu, Chun Ping ^b   Wu, Dong Hui ^a   Zhang, Ling ^b   Xu, Li Hua ^b   Weng, Gui Xiang ^b   Zeng, Mu Sheng ^b   Song, Li Bing ^b   Li, Jin Song ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE PROTEIN A; CENTROMERE PROTEIN H; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG; CENPH PROTEIN, HUMAN; MESSENGER RNA; NONHISTONE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONGUE CANCER; WESTERN BLOTTING; APOPTOSIS; CELL PROLIFERATION; CLONOGENIC ASSAY; DISEASE COURSE; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE; TONGUE; TONGUE TUMOR; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CHROMOSOMAL PROTEINS, NON-HISTONE; COLONY-FORMING UNITS ASSAY; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TONGUE; TONGUE NEOPLASMS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 67651152867     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-74     Document Type: Article

References (34)

1. Assembly of kinetochores in vertebrate cells. T Fukagawa, Exp Cell Res 2004 296 21 27 10.1016/j.yexcr.2004.03.004 15120989 (Pubitemid 38543208)
2. Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. DW Cleveland Y Mao KF Sullivan, Cell 2003 112 407 421 10.1016/S0092-8674(03)00115-6 12600307 (Pubitemid 36263076)
3. Architecture of the budding yeast kinetochore reveals a conserved molecular core. S Westermann IM Cheeseman S Anderson JR Yates 3rd DG Drubin G Barnes, J Cell Biol 2003 163 215 222 14581449 10.1083/jcb.200305100 (Pubitemid 37363122)
4. Simple centromere, complex kinetochore: linking spindle microtubules and centromeric DNA in budding yeast. IM Cheeseman DG Drubin G Barnes, J Cell Biol 2002 157 199 203 11956223 10.1083/jcb.200201052 (Pubitemid 34839816)
5. Hierarchical assembly of the budding yeast kinetochore from multiple subcomplexes. P De Wulf AD McAinsh PK Sorger, Genes Dev 2003 17 2902 2921 14633972 10.1101/gad.1144403 (Pubitemid 37523155)
6. Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. T Tomonaga K Matsushita M Ishibashi M Nezu H Shimada T Ochiai K Yoda F Nomura, Cancer Res 2005 65 4683 4689 10.1158/0008-5472.CAN-04-3613 15930286 (Pubitemid 40740804)
7. INCENP (Inner Centromere Protein) is Overexpressed in High Grade Non-Hodgkin B-cell Lymphomas. S Barbanis M Ioannou E Kouvaras F Karasavvidou M Nakou R Papamichali G Koukoulis, Pathol Oncol Res 2009 15 11 17 10.1007/s12253-008-9094-0 18752045
8. Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma. M Erlanson CA Casiano EM Tan J Lindh G Roos G Landberg, Mod Pathol 1999 12 69 74 9950165
9. Correlation of CENP-F gene expression with tumor-proliferating activity in human salivary gland tumors. H Shigeishi K Mizuta K Higashikawa S Yoneda S Ono N Kamata, Oral Oncol 2005 41 716 722 10.1016/j.oraloncology.2005.03.008 15927522 (Pubitemid 40981112)
10. Characterization of a novel kinetochore protein, CENP-H. N Sugata E Munekata K Todokoro, J Biol Chem 1999 274 27343 27346 10.1074/jbc.274.39.27343 10488063 (Pubitemid 29457971)
11. CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells. T Fukagawa Y Mikami A Nishihashi V Regnier T Haraguchi Y Hiraoka N Sugata K Todokoro W Brown T Ikemura, Embo J 2001 20 4603 4617 11500386 10.1093/emboj/20.16.4603 (Pubitemid 32772053)
12. Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere - kinetochore complexes. N Sugata S Li WC Earnshaw TJ Yen K Yoda H Masumoto E Munekata PE Warburton K Todokoro, Hum Mol Genet 2000 9 2919 2926 10.1093/hmg/9.19.2919 11092768
13. KNL1 and the CENP-H/I/K Complex Coordinately Direct Kinetochore Assembly in Vertebrates. IM Cheeseman T Hori T Fukagawa A Desai, Mol Biol Cell 2008 19 587 594 18045986 10.1091/mbc.E07-10-1051 (Pubitemid 351272147)
14. CENP-O class proteins form a stable complex and are required for proper kinetochore function. T Hori M Okada K Maenaka T Fukagawa, Mol Biol Cell 2008 19 843 854 18094054 10.1091/mbc.E07-06-0556
15. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. WT Liao LB Song HZ Zhang X Zhang L Zhang WL Liu Y Feng BH Guo HQ Mai SM Cao MZ Li HD Qin YX Zeng MS Zeng, Clin Cancer Res 2007 13 508 514 10.1158/1078-0432.CCR-06-1512 17255272 (Pubitemid 46225356)
16. Prognostic relevance of Centromere protein H expression in esophageal carcinoma. XZ Guo G Zhang JY Wang WL Liu F Wang JQ Dong LH Xu JY Cao LB Song MS Zeng, BMC Cancer 2008 8 233 18700042 10.1186/1471-2407-8-233
17. Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity. H Shigeishi K Higashikawa S Ono K Mizuta Y Ninomiya S Yoneda M Taki N Kamata, Oncol Rep 2006 16 1071 1075 17016595
18. Chromosomal instability in oral cancer cells. SC Reshmi SM Gollin, J Dent Res 2005 84 107 117 10.1177/154405910508400203 15668327 (Pubitemid 43822042)
19. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. JS Greenberg R Fowler J Gomez V Mo D Roberts AK El Naggar JN Myers, Cancer 2003 97 1464 1470 10.1002/cncr.11202 12627511 (Pubitemid 36297776)
20. Natural history and patterns of recurrence of tongue tumours. KJ Haddadin DS Soutar MH Webster AG Robertson RJ Oliver DG MacDonald, Br J Plast Surg 2000 53 279 285 10.1054/bjps.1999.1111 10876250 (Pubitemid 30386856)
21. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. LB Song MS Zeng WT Liao L Zhang HY Mo WL Liu JY Shao QL Wu MZ Li YF Xia LW Fu WL Huang GP Dimri V Band YX Zeng, Cancer Res 2006 66 6225 6232 10.1158/0008-5472.CAN-06-0094 16778197
22. TNM staging of cancers of the head and neck: striving for uniformity among diversity. SG Patel JP Shah, CA Cancer J Clin 2005 55 242 258 10.3322/canjclin.55.4.242 16020425
23. New TNM staging criteria for head and neck tumors. B O'Sullivan J Shah, Semin Surg Oncol 2003 21 30 42 10.1002/ssu.10019 12923914 (Pubitemid 37127472)
24. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. WT Liao X Wang LH Xu QL Kong CP Yu MZ Li L Shi MS Zeng LB Song, Cancer 2009 115 1507 1017 10.1002/cncr.24128 19170237
25. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. C Jane AV Nerurkar NV Shirsat RB Deshpande AD Amrapurkar FR Karjodkar, J Oral Pathol Med 2006 35 595 601 10.1111/j.1600-0714.2006.00473.x 17032391 (Pubitemid 44525636)
26. On the road to cancer: aneuploidy and the mitotic checkpoint. GJ Kops BA Weaver DW Cleveland, Nat Rev Cancer 2005 5 773 785 10.1038/nrc1714 16195750 (Pubitemid 41400777)
27. CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. C de la Guardia CA Casiano J Trinidad-Pinedo A Baez, Head Neck 2001 23 104 112 10.1002/1097-0347(200102)23:2<104::AID-HED1005>3.0.CO;2-0 11303627
28. Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer. GM Clark DC Allred SG Hilsenbeck GC Chamness CK Osborne D Jones WH Lee, Cancer Res 1997 57 5505 5508 9407959
29. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. A Carvalho M Carmena C Sambade WC Earnshaw SP Wheatley, J Cell Sci 2003 116 2987 2998 10.1242/jcs.00612 12783991 (Pubitemid 36926987)
30. The case for Survivin as mitotic regulator. SM Lens G Vader RH Medema, Curr Opin Cell Biol 2006 18 616 622 10.1016/j.ceb.2006.08.016 16962308 (Pubitemid 44711886)
31. Survivin, versatile modulation of cell division and apoptosis in cancer. DC Altieri, Oncogene 2003 22 8581 8589 10.1038/sj.onc.1207113 14634620 (Pubitemid 38019195)
32. Control of apoptosis and mitotic spindle checkpoint by survivin. F Li G Ambrosini EY Chu J Plescia S Tognin PC Marchisio DC Altieri, Nature 1998 396 580 584 10.1038/25141 9859993 (Pubitemid 28563719)
33. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. L Lo Muzio A Farina C Rubini F Pezzetti G Stabellini G Laino A Santarelli G Pannone P Bufo A de Lillo F Carinci, Cancer Lett 2005 225 27 33 10.1016/j.canlet.2004.11.024 15922854 (Pubitemid 40732765)
34. Survivin, a potential early predictor of tumor progression in the oral mucosa. L Lo Muzio G Pannone R Leonardi S Staibano MD Mignogna G De Rosa Y Kudo T Takata DC Altieri, J Dent Res 2003 82 923 928 10.1177/154405910308201115 14578507